Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1997-10-9
pubmed:abstractText
The use of corticosteroids in active Crohn's disease often becomes limited by side effects. Budesonide is a potent corticosteroid with low systemic bioavailability due to an extensive first pass liver metabolism.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9301500-1248701, http://linkedlifedata.com/resource/pubmed/commentcorrection/9301500-1382936, http://linkedlifedata.com/resource/pubmed/commentcorrection/9301500-1676590, http://linkedlifedata.com/resource/pubmed/commentcorrection/9301500-1886623, http://linkedlifedata.com/resource/pubmed/commentcorrection/9301500-1968879, http://linkedlifedata.com/resource/pubmed/commentcorrection/9301500-2846506, http://linkedlifedata.com/resource/pubmed/commentcorrection/9301500-38176, http://linkedlifedata.com/resource/pubmed/commentcorrection/9301500-6140202, http://linkedlifedata.com/resource/pubmed/commentcorrection/9301500-769625, http://linkedlifedata.com/resource/pubmed/commentcorrection/9301500-7696447, http://linkedlifedata.com/resource/pubmed/commentcorrection/9301500-7696452, http://linkedlifedata.com/resource/pubmed/commentcorrection/9301500-8078529, http://linkedlifedata.com/resource/pubmed/commentcorrection/9301500-8078530, http://linkedlifedata.com/resource/pubmed/commentcorrection/9301500-8078535, http://linkedlifedata.com/resource/pubmed/commentcorrection/9301500-8161666
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0017-5749
pubmed:author
pubmed:issnType
Print
pubmed:volume
41
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
209-14
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:9301500-Acute Disease, pubmed-meshheading:9301500-Administration, Oral, pubmed-meshheading:9301500-Adolescent, pubmed-meshheading:9301500-Adult, pubmed-meshheading:9301500-Aged, pubmed-meshheading:9301500-Anti-Inflammatory Agents, pubmed-meshheading:9301500-Budesonide, pubmed-meshheading:9301500-Colitis, pubmed-meshheading:9301500-Crohn Disease, pubmed-meshheading:9301500-Delayed-Action Preparations, pubmed-meshheading:9301500-Double-Blind Method, pubmed-meshheading:9301500-Drug Administration Schedule, pubmed-meshheading:9301500-Female, pubmed-meshheading:9301500-Humans, pubmed-meshheading:9301500-Hydrocortisone, pubmed-meshheading:9301500-Ileitis, pubmed-meshheading:9301500-Leukocyte Count, pubmed-meshheading:9301500-Male, pubmed-meshheading:9301500-Middle Aged, pubmed-meshheading:9301500-Prednisolone, pubmed-meshheading:9301500-Pregnenediones
pubmed:year
1997
pubmed:articleTitle
Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group.
pubmed:affiliation
Medical and Gastroenterological Clinic, University of Bologna, Italy.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't